Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

What made ribose the sugar of choice for life's code? Scientists at Scripps Research may have cracked a major part of this ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA ...

Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...

This is a well-written study that presents a solid genetic screen to identify regulators of adipose morphology and remodeling in zebrafish. The authors generated a rigorous screening platform based on ...

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapiesCORALVILLE, Iowa ...

Scientists developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously adjust their therapeutic effect.

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA candidates. Click for my look at BNTX and CVAC.

BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring fellow mRNA company CureVac in a $1.25 billion stock deal that brings ...

In axing mRNA contract, Trump delivers another blow to US biosecurity, former officials say The administration has been gutting health agencies and cutting research.

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic technology.